DK1373255T3 - Fremgangsmåde til fremstilling af imidazolforbindelser - Google Patents

Fremgangsmåde til fremstilling af imidazolforbindelser

Info

Publication number
DK1373255T3
DK1373255T3 DK02722184T DK02722184T DK1373255T3 DK 1373255 T3 DK1373255 T3 DK 1373255T3 DK 02722184 T DK02722184 T DK 02722184T DK 02722184 T DK02722184 T DK 02722184T DK 1373255 T3 DK1373255 T3 DK 1373255T3
Authority
DK
Denmark
Prior art keywords
preparation
imidazole compounds
imidazole
compounds
Prior art date
Application number
DK02722184T
Other languages
Danish (da)
English (en)
Inventor
Walter F M Filliers
Rudy L M Broeckx
Stefan M H Leurs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1373255T3 publication Critical patent/DK1373255T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
DK02722184T 2001-03-12 2002-03-05 Fremgangsmåde til fremstilling af imidazolforbindelser DK1373255T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200928 2001-03-12
PCT/EP2002/002459 WO2002072574A1 (en) 2001-03-12 2002-03-05 Process for the preparation of imidazole compounds

Publications (1)

Publication Number Publication Date
DK1373255T3 true DK1373255T3 (da) 2005-05-23

Family

ID=8180004

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02722184T DK1373255T3 (da) 2001-03-12 2002-03-05 Fremgangsmåde til fremstilling af imidazolforbindelser

Country Status (32)

Country Link
US (1) US6844439B2 (no)
EP (1) EP1373255B1 (no)
JP (1) JP4257698B2 (no)
KR (1) KR100849042B1 (no)
CN (1) CN1246318C (no)
AR (1) AR035944A1 (no)
AT (1) ATE287882T1 (no)
AU (1) AU2002253101B2 (no)
BR (1) BRPI0208075B8 (no)
CA (1) CA2438421C (no)
CZ (1) CZ300622B6 (no)
DE (1) DE60202755T2 (no)
DK (1) DK1373255T3 (no)
EA (1) EA006770B1 (no)
EE (1) EE05247B1 (no)
ES (1) ES2236505T3 (no)
HK (1) HK1063315A1 (no)
HR (1) HRP20030695B1 (no)
HU (1) HU230282B1 (no)
IL (2) IL157839A0 (no)
MX (1) MXPA03008205A (no)
MY (1) MY124838A (no)
NO (1) NO324954B1 (no)
NZ (1) NZ528620A (no)
PL (1) PL208238B1 (no)
PT (1) PT1373255E (no)
SI (1) SI1373255T1 (no)
SK (1) SK287807B6 (no)
TW (1) TWI249532B (no)
UA (1) UA74871C2 (no)
WO (1) WO2002072574A1 (no)
ZA (1) ZA200307117B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2291455T3 (es) 2001-03-12 2008-03-01 Avanir Pharmaceuticals Compuestos de bencimidazol para modular ige e inhibir la proliferacion celular.
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
JP2007538004A (ja) * 2004-03-18 2007-12-27 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド シヌクレイノパチーを治療する方法
US7524961B2 (en) 2004-05-03 2009-04-28 Janssen Pharmaceutica, N.V. Diastereoselective addition of lithiated N-methylimidazole on sulfinimines
JP4917022B2 (ja) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 6−ブロモ−4−(3−クロロフェニル)−2−メトキシ−キノリンを用いるジアステレオ選択的合成方法
ATE397600T1 (de) 2004-05-03 2008-06-15 Janssen Pharmaceutica Nv Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungen
EP1968591A4 (en) 2005-12-23 2010-02-17 Link Medicine Corp TREATMENT OF SYNUCLEINOPATHIES
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
KR101044430B1 (ko) * 2009-09-25 2011-06-27 듀오백코리아 주식회사 요추받이를 포함하는 의자의 등 지지 장치
KR101107900B1 (ko) * 2009-10-21 2012-01-25 성용기업 주식회사 의자용 허리지지장치
PT3277842T (pt) 2015-08-17 2019-09-05 Kura Oncology Inc Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
EP3838275A1 (en) 2016-11-03 2021-06-23 Kura Oncology, Inc. Farnesyltransferase inhibitors for use in methods of treating cancer
US10954210B2 (en) 2016-12-08 2021-03-23 Hangzhou Solipharma Co., Ltd. Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
AU2019270163A1 (en) * 2018-05-18 2020-12-03 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
SI1162201T1 (sl) * 1995-12-08 2006-08-31 Janssen Pharmaceutica Nv (Imidazol-5-il)metil-2-kinolinonski derivati kot inhibitorji farnezil protein transferaze
TW591030B (en) 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
CA2288140C (en) 1997-04-25 2007-04-03 Janssen Pharmaceutica N.V. Farnesyltransferase inhibiting quinazolinones
JP3495706B2 (ja) * 1998-08-27 2004-02-09 ファイザー・プロダクツ・インク 抗癌薬として有用なアルキニル置換キノリン−2−オン誘導体
ES2237125T3 (es) 1998-08-27 2005-07-16 Pfizer Products Inc. Derivados de quinolin-2-ona utiles como agentes anticancerigenos.

Also Published As

Publication number Publication date
CN1496363A (zh) 2004-05-12
CZ300622B6 (cs) 2009-07-01
NO20034003L (no) 2003-10-22
WO2002072574A1 (en) 2002-09-19
EA200300998A1 (ru) 2004-02-26
MY124838A (en) 2006-07-31
US20040138256A1 (en) 2004-07-15
SK12462003A3 (sk) 2004-06-08
MXPA03008205A (es) 2004-01-29
BRPI0208075B8 (pt) 2021-05-25
KR20030079971A (ko) 2003-10-10
HK1063315A1 (en) 2004-12-24
ZA200307117B (en) 2004-09-13
CA2438421A1 (en) 2002-09-19
PT1373255E (pt) 2005-05-31
HRP20030695B1 (en) 2011-07-31
NO20034003D0 (no) 2003-09-10
HRP20030695A2 (en) 2005-02-28
SI1373255T1 (no) 2005-08-31
SK287807B6 (sk) 2011-10-04
HUP0303443A3 (en) 2012-09-28
TWI249532B (en) 2006-02-21
NO324954B1 (no) 2008-01-14
CZ20032704A3 (en) 2004-03-17
AR035944A1 (es) 2004-07-28
HUP0303443A2 (hu) 2004-01-28
AU2002253101B2 (en) 2007-08-09
CA2438421C (en) 2010-05-18
IL157839A (en) 2008-07-08
PL363263A1 (en) 2004-11-15
IL157839A0 (en) 2004-03-28
EE200300442A (et) 2003-12-15
EP1373255A1 (en) 2004-01-02
JP2004523575A (ja) 2004-08-05
DE60202755D1 (de) 2005-03-03
EP1373255B1 (en) 2005-01-26
BR0208075A (pt) 2004-03-02
CN1246318C (zh) 2006-03-22
PL208238B1 (pl) 2011-04-29
EE05247B1 (et) 2009-12-15
KR100849042B1 (ko) 2008-07-29
ES2236505T3 (es) 2005-07-16
ATE287882T1 (de) 2005-02-15
BRPI0208075B1 (pt) 2018-02-14
US6844439B2 (en) 2005-01-18
DE60202755T2 (de) 2006-03-30
JP4257698B2 (ja) 2009-04-22
NZ528620A (en) 2005-01-28
UA74871C2 (en) 2006-02-15
EA006770B1 (ru) 2006-04-28
HU230282B1 (hu) 2015-12-28

Similar Documents

Publication Publication Date Title
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1432707T3 (da) Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme
DK1651622T3 (da) Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1794152T3 (da) Fremgangsmåde til fremstilling af enantiomeriske imidazol-forbindelser
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner
DK1353930T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
DK1281707T3 (da) Fremgangsmåde til fremstilling af 5-substituerede isobenzenfuraner
DK1254159T3 (da) Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider
DK1591122T3 (da) Fremgangsmåde til indgivelse af bisphosphonater